Uterine papillary serous carcinoma: a new paradigm for treatment?
Annunziata
Christina M
CM
Medical Oncology Branch, National Cancer Institute, Bethesda, MD, USA. annunzic@mail.nih.gov
Kotz
Herbert L
HL
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018283:Cystadenocarcinoma, Papillary / Q000188:drug therapy / Q000235:genetics / Q000532:radiotherapy / Q000628:therapy*; D005260:Female; D006801:Humans; D018365:Neoplasm, Residual; D012008:Recurrence; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000532:radiotherapy / Q000628:therapy*